Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 11, 2005, Pages 1731-1740

  Bahnassi, Abeer A ^a   Zekri, Abdel Rahman N ^b   El Houssini, Soumaya ^a   Mokhtar, Nadia M ^a   Abdel Aziz, Asraf O ^c   Sherif, Ghada M ^b   El Mishad, Abla M ^c   Khaled, Hussein M ^b  

^a NATIONAL CANCER INSTITUTE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Non structural protein of HCV; Oncogenes; Tumor suppressor genes

Indexed keywords

NONSTRUCTURAL PROTEIN 3; VIRUS DNA; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MDM2 PROTEIN, HUMAN; NS3 PROTEIN, HEPATITIS C VIRUS; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SERINE PROTEINASE; VIRUS PROTEIN;

ADOLESCENT; ADULT; ARTICLE; C ERBB2 GENE; CANCER GRADING; CARCINOGENICITY; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EGYPT; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CIRRHOSIS; MALE; MALIGNANT TRANSFORMATION; MDM2 GENE; NS3P GENE; P21WAF GENE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TUMOR SUPPRESSOR GENE; VIRUS GENOME; AGED; CHILD; GENETICS; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MIDDLE AGED; PLOIDY;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA, NEOPLASM; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLOIDIES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, ERBB-2; SERINE ENDOPEPTIDASES; TUMOR SUPPRESSOR PROTEIN P53; VIRAL NONSTRUCTURAL PROTEINS;

EID: 33644797796     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04002.x     Document Type: Article

References (35)

1. Otsuka M, Kato N, Lan K et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J. Biol. Chem. 2000 275 : 34122 30.
2. Attia MA, Zekri AR, Goudsmit J et al. Diverse patterns of recognition of hepatitis C virus core and non-structural antigens by antibodies present in Egyptian cancer patients and blood donors. J. Clin. Microbiol. 1996 34 : 2665 9.
3. Zekri AR, Bahnassy AA, Shaarawy SM et al. Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. J. Med. Microbiol. 2000 49 : 89 95.
4. Zekri A-RN, Bahnassy AA, Ramadan AS, El-Bassuoni M, Badran A, Madwar MA. HCV genotyping vs serotyping in Egyptian patients. Infection 2001 29 : 24 6.
5. Bartenschlager R. The NS3/4A proteinase of the hepatitis C virus. Unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J. Viral Hepat. 1999 6 : 165 81.
6. Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL. p53 dependent transcriptional repression of p21 (WAF1) by hepatitis C virus NS3. J. Gen. Virol. 2001 82 : 2235 41.
7. Zemel R, Kazatsker A, Greif F et al. Mutations at vicinity of catalytic sites of hepatitis C virus NS3 serine protease gene isolated from hepatocellular carcinoma tissue. Dig. Dis. Sci. 2000 45 : 2199 202.
8. Feng D, Zheng H, Yan Y. The effect of HCV NS3 protein on expression of p53 gene protein in hepatocarcinogenesis. Zhonghua Yi Xue Za Zhi 1998 78 : 278 80 (In Chinese).
9. Steegenga WT, van Laar T, Riteco N et al. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell Biol. 1996 16 : 2101 9.
10. Murono S, Yoshizaki T, Park CS, Furukawa M. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma. Histopathology 1999 34 : 432 8.
11. Schlott T, Ahrens K, Ruschenburg I, Reimer S, Hartmann H, Droese M. Different gene expression of MDM2, GAGE-1,-2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. Br. J. Cancer 1999 80 : 73 8.
12. Livni N, Eid A, Ilan Y et al. p53 expression in patients with cirrhosis with and without hepatocellular carcinoma. Cancer 1995 75 : 2420 6.
13. Qin LF, Ng IO, Fan ST, Ng M. p21/WAF, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int. J. Cancer 1998 79 : 424 8.
14. Hui AM, Kanai Y, Sakamoto M, Tsuda H, Hirohashi S. Reduced p21 WAF1/CIP1 expression and p53 mutation in hepatocellular carcinoma. Hepatology 1997 25 : 575 9.
15. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 1994 54 : 3391 5.
16. Shi YZ, Hui AM, Takayama T, Li X, Cui X, Makuuchi M. Reduced p21WAF1/CIP1 expression is predominantly related to altered p53 in hepatocellular carcinomas. Br. J. Cancer 2000 83 : 50 5.
17. Heinze T, Jonas S, Karsten A, Neuhaus P. Determination of the oncogenes p53 and c-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time. Anticancer Res. 1999 19 : 2501 3.
18. Voravud N, Foster CS, Gilbertson JA, Sikora K, Waxman J. Oncogene expression in cholangiocarcinoma and normal hepatic development. Hum. Pathol. 1998 20 : 1163 8.
19. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21 Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 2001 3 : 245 52.
20. Ayllon V, Rebollo A. Ras-induced cellular events (Review). Mol. Membr. Biol. 2000 17 : 65 73.
21. Thompson NL, Mead JE, Braun L, Goyette M, Shank PR, Fausto N. Sequential protooncogene expression during rat liver regeneration. Cancer Res. 1986 46 : 3111 17.
22. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 1996 70 : 4438 43.
23. Haritani H, Esumi M, Uchida T, Shikata T. Oncogene expression in the liver tissue of patients with non-neoplastic liver disease. Pathology 1990 67 : 2594 8.
24. Attallah AM, Tabll AA, Salem SF et al. DNA ploidy of liver biopsies from patients with liver cirrhosis and hepatocellular carcinoma: A flowcytometric analysis. Cancer Lett. 1999 142 : 65 9.
25. Terris B, Laurent-Puig P, Belghitti J, Degatt C, Henin D, Flejou JF. Prognostic influence of clinicopathologic features, DNA ploidy, CD44H and p53 expression in a large series of a resected hepatocellular carcinoma in France. Int. J. Cancer 1997 74 : 614 19.
26. Ng LOL, Lai ECS, Fan ST, Ng MMT, So MKP. Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer 1995 76 : 2443 8.
27. Boom R, Sol CJ, Heijtink R, Wertheim-van Dillen PM, van der Noordaa J. Rapid purification of hepatitis B virus DNA from serum. J. Clin. Microbiol. 1991 29 : 1804 11.
28. Vargas-Roig IM, Gago FE, Tello O, Martinde-Civetto MT, Ciocca DR. C-erbB2 (Her-2/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer 1999 84 : 129 34.
29. Shakeny TV, Rabinovitch PS, Bagwell B, Baur KD. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993 14 : 472 7.
30. Okuda K. Hepatocellular carcinoma. J. Hepatol. 2000 32 : 225 37.
31. Asada M, Yamada T, Ichijo H et al. Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. EMBO J. 1999 18 : 1223 34.
32. Zhu B, Cong W, Wang H. WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutations. Zhonghua Gan Zang Bing Za Zhi 1999 7 : 217 20 (In Chinese).
33. Naka T, Toyota N, Kaneko T, Kaibara N. Protein expression of p53, p21waf and Rb as prognostic indicates in patients with surgically treated hepatocellular carcinoma. Anti Cancer Res. 1998 18 : 555 64.
34. Ng IO. Prognostic significance of pathological and biological factors in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1998 13 : 666 70.
35. Zeppa P, Benincasa G, Troncone G et al. Retrospective evaluation of DNA ploidy of hepatocarcinoma on cytologic samples. Diagn. Cytopathol. 1998 19 : 323 9.